声带息肉患者手术与嗓音治疗短期结局的比较
回顾性病例系列研究纳入2010年1月至2016年4月诊断的120例声带息肉患者,比较单纯嗓音治疗(VT=29例)、单纯手术(SUR=23例)及嗓音治疗联合手术(VTS=68例)的短期结局。SUR组和VTS组治疗前后VHI-10评分改善显著优于VT组(P=.009),GRBAS评分各组均无显著变化。作者认为涉及手术的治疗方案短期患者报告结局获益最大,单纯嗓音治疗无显著短期改变,需进一步研究长期结局。
要点
- 120例声带息肉患者中,SUR组23例(19.2%)、VT组29例(24.2%)、VTS组68例(56.7%),平均随访5.5个月。
- SUR组VHI-10平均改善12.5(SD=12.7),VTS组平均改善12.3(SD=10.3),VT组平均改善2.84(SD=11.9),组间比较P=.009。
- GRBAS评分各组治疗前后均无显著变化,115例(95.8%)无复发。
核心结论
- 采用患者报告结局指标时,声带息肉患者从涉及手术或手术联合嗓音治疗的治疗方案中获得最大的短期获益。
- 单纯嗓音治疗未导致显著的短期变化。
- 各组的感知嗓音特征均无显著变化。
- 需要对声带息肉患者的长期治疗结局进一步研究。
研究设计与样本
- 回顾性病例系列研究,纳入2010年1月至2016年4月诊断的声带息肉患者(国际疾病分类第九版编码478.4和第十版编码J38.1)。
- 纳入标准为年龄大于18岁且有接受嗓音治疗、手术或两者联合治疗的病历记录;排除标准为喉癌病史或锁骨以上区域放疗史。
- 共识别120例声带息肉患者:SUR组23例(19.2%),VT组29例(24.2%),VTS组68例(56.7%)。
- 平均随访5.5个月。
主要发现
- 115例患者(95.8%)无复发。
- SUR组VHI-10评分治疗前后平均改善12.5(SD=12.7),VTS组平均改善12.3(SD=10.3),VT组平均改善2.84(SD=11.9),组间比较P=.009。
- 各组的GRBAS评分治疗前后均无显著变化。
临床怎么用
- 作者认为,采用患者报告结局指标时,涉及手术或手术联合嗓音治疗的治疗方案可使声带息肉患者获得最大的短期获益。
- 作者指出单纯嗓音治疗未导致显著的短期变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Optimal treatment for patients with vocal fold polyps (VFPs) remains controversial. We compared the short-term outcomes of treatment with voice therapy alone (VT), surgery alone (SUR)m or voice therapy and surgery (VTS). STUDY DESIGN: Retrospective case series. METHODS: A retrospective study was performed for patients diagnosed with VFP (International Classification of Diseases, Ninth Revision code 478.4 and Tenth Revision code J38.1) between January 2010 and April 2016. Inclusion criteria were age greater than 18 years and charted evidence of treatment with voice therapy, surgery, or both. Exclusion criteria were history of laryngeal cancer or radiation above the clavicles. Outcomes measured included chart records of lesion absence, persistence or recurrence, and differences between pretreatment and post-treatment Voice Handicap Index-10 and GRBAS (G/grade, R/roughness, B/breathiness, A/asthenia, S/strain) scores. RESULTS: One hundred twenty patients with VFPs were identified (SUR = 23, 19.2%, VT = 29, 24.2%, VTS = 68, 56.7%). Mean follow-up was 5.5 months. There were no recurrences in 115 patients (95.8%). There was significant improvement from pre- to post-treatment VHI-10 scores in the SUR (mean improvement = 12.5, standard deviation [SD] = 12.7) and VTS (mean improvement = 12.3, SD = 10.3) groups compared to the VT (mean improvement = 2.84, SD = 11.9) group (P = .009). Pre- and post-treatment GRBAS scores did not significantly change in any group. CONCLUSIONS: When using patient-reported outcomes measures, patients with VFPs receive the greatest short-term gains from treatment paradigms involving surgery or a combination of surgery and voice therapy. Voice therapy alone did not result in significant short-term changes. Perceptual voice characteristics did not change significantly for any group. Further research on long-term treatment outcomes for patients with VFPs is needed. LEVEL OF EVIDENCE: 3 Laryngoscope, 129:1067-1070, 2019.
引用
- Agarwal J, Wong A, Karle W, et al. Comparing short-term outcomes of surgery and voice therapy for patients with vocal fold polyps. Laryngoscope. 2019. PMID: 30604483. doi:10.1002/lary.27697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。